In a case study, RT treatment coincided with declines in T cells, B cells, pDCs and NK cells, and a shift of the CD4:CD8 ratio correlated with MRI tumor recurrence offering some hope in the identification of treatment response or prognostic indicators [6]. This evidence concerns the gene CD8A and neoplasm.